ACHV - Achieve Life Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.66M
Enterprise Value 34.63M
Trailing P/E N/A
Forward P/E 1-1.20
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.27
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.28

Trading Information

Stock Price History

Beta (3Y Monthly) 1.76
52-Week Change 3-41.78%
S&P500 52-Week Change 3-0.33%
52 Week High 35.2500
52 Week Low 31.0400
50-Day Moving Average 31.8521
200-Day Moving Average 32.7609

Share Statistics

Avg Vol (3 month) 3193.26k
Avg Vol (10 day) 398.5k
Shares Outstanding 512.75M
Float 7.21M
% Held by Insiders 14.97%
% Held by Institutions 128.42%
Shares Short (Jul 31, 2019) 4361.31k
Short Ratio (Jul 31, 2019) 42.91
Short % of Float (Jul 31, 2019) 45.66%
Short % of Shares Outstanding (Jul 31, 2019) 44.62%
Shares Short (prior month Jun 28, 2019) 4398.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3May 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-61.09%
Return on Equity (ttm)-117.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.35M
Net Income Avi to Common (ttm)-16.41M
Diluted EPS (ttm)-2.6060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.45M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)419k
Total Debt/Equity (mrq)3.64
Current Ratio (mrq)3.62
Book Value Per Share (mrq)1.42

Cash Flow Statement

Operating Cash Flow (ttm)-15.25M
Levered Free Cash Flow (ttm)-9.11M